8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.05%
Negative revenue growth while 3141.T stands at 4.25%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.70%
Negative gross profit growth while 3141.T is at 11.49%. Joel Greenblatt would examine cost competitiveness or demand decline.
-30.38%
Negative EBIT growth while 3141.T is at 83.75%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-24.93%
Negative operating income growth while 3141.T is at 112.21%. Joel Greenblatt would press for urgent turnaround measures.
-19.88%
Negative net income growth while 3141.T stands at 92.58%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-19.88%
Negative EPS growth while 3141.T is at 92.59%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-19.88%
Negative diluted EPS growth while 3141.T is at 92.74%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 3141.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.62%
10Y revenue/share CAGR under 50% of 3141.T's 154.55%. Michael Burry would suspect a lasting competitive disadvantage.
50.86%
5Y revenue/share CAGR at 75-90% of 3141.T's 64.74%. Bill Ackman would encourage strategies to match competitor’s pace.
25.47%
3Y revenue/share CAGR at 75-90% of 3141.T's 31.51%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
43.16%
Below 50% of 3141.T's 724.99%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
22.93%
Below 50% of 3141.T's 121.58%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
21.41%
Below 50% of 3141.T's 78.57%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
173.04%
10Y equity/share CAGR at 50-75% of 3141.T's 279.36%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
113.90%
5Y equity/share CAGR above 1.5x 3141.T's 75.23%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
53.95%
3Y equity/share CAGR 1.25-1.5x 3141.T's 40.31%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
122.22%
Below 50% of 3141.T's 500.00%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
128.57%
Similar 5Y dividend/share CAGR to 3141.T's 140.00%. Walter Schloss sees parallel philosophies in mid-term capital returns.
77.78%
3Y dividend/share CAGR above 1.5x 3141.T's 42.86%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
49.38%
AR growth well above 3141.T's 5.00%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.80%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.73%
Asset growth well under 50% of 3141.T's 2.52%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.86%
Under 50% of 3141.T's 5.93%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-7.13%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
1.19%
SG&A growth well above 3141.T's 0.60%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.